Genomics Bioscience & Technology Co

Genomics Bioscience & Technology Co Acquisitions (Net)

The Acquisitions (Net) of Genomics Bioscience & Technology Co (4195.TWO) as of Oct 18, 2026 is -100.49 M TWD. In the previous year, Acquisitions (Net) was -6.37 M TWD — a change of 1,478.06% (lower).

Acquisitions (Net)

-100.49 MTWD

YoY

1,478.06%

Last updated:

Acquisitions (Net) of Genomics Bioscience & Technology Co is 2024 -100.49 M TWD. Acquisitions (Net) of Genomics Bioscience & Technology Co was 2023 -6.37 M TWD. It decreases by 1,478.06% lower compared to the previous year.

The Genomics Bioscience & Technology Co Acquisitions (Net) history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Acquisitions (Net)
Date
Acquisitions (Net)
Jan 1, 2017
-60.66 M TWD
Jan 1, 2018
1.12 M TWD
Jan 1, 2019
111.46 M TWD
Jan 1, 2020
-76.45 M TWD
Jan 1, 2021
-169.82 M TWD
Jan 1, 2022
123.06 M TWD
Jan 1, 2023
-6.37 M TWD
Jan 1, 2024
-100.49 M TWD
The Genomics Bioscience & Technology Co Acquisitions (Net) history
YEARAcquisitions (Net)YoY
-100.49 MTWD+1,478.06%
-6.37 MTWD-105.17%
123.06 MTWD-172.46%
-169.82 MTWD+122.13%
-76.45 MTWD-168.59%
111.46 MTWD+9,869.95%
1.12 MTWD-101.84%
-60.66 MTWD+845.37%
-6.42 MTWD-295.43%
3.28 MTWD-97.92%
157.57 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Genomics Bioscience & Technology Co Stock analysis

What does Genomics Bioscience & Technology Co do? Genomics Bioscience & Technology Co Ltd, based in Taipei, Taiwan, operates in the Health Care sector within the Biotechnology industry. The company focuses on manufacturing, research, and development of biotechnological products and services. It provides public and clinical gene sequencing services, including preventive genetic testing, primer synthesis, and cancer screening. Additionally, it manufactures and sells biochemical instruments, reagents, and consumables, distributing them domestically and internationally. Genomics Bioscience & Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genomics Bioscience & Technology Co stock

Acquisitions (Net) of Genomics Bioscience & Technology Co is -100.49 M TWD in 2024.

Acquisitions (Net) of Genomics Bioscience & Technology Co changed from -6.37 M TWD to -100.49 M TWD, representing a 1,478.06% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Acquisitions (Net) Genomics Bioscience & Technology Co since 2006 – with annual values, charts, and detailed analysis.

Net acquisitions represent the cash spent on acquiring other businesses, net of divestitures. Large acquisitions can transform a company's growth trajectory.

Acquisitions (Net)'s TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Acquisitions (Net)'s Genomics Bioscience & Technology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Genomics Bioscience & Technology Co

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Genomics Bioscience & Technology Co